As a government price-setting formula, the same arithmetic has produced the opposite result.
|Articles|October 19, 2007
Groups tell Congress to back off fight over ESA dosing decisions
Groups say cancer drug dosing best measured by CMS, Medicaid.
Advertisement
A handful of consumer and health groups have fired the latest salvo in the ongoing battle over Medicare reimbursements for anemia drugs. In a letter sent Wednesday to Congress, the groups-including Consumers Union, U.S. PIRG, the National Research Center for Women & Families, the National Women's Health Network, and the Center for Medical Consumers-urged lawmakers to back off the fight over a CMS
Advertisement
Related to this article
Orforglipron lowered A1C and body weight more than oral semaglutide 25 mg at 52 weeks, but the estimate comes from an indirect comparison.
Brian Smith, PharmD, explains how direct-to-consumer GLP-1 pathways broaden initial access but endanger long-term patient adherence.
Pharmacists face burnout and financial strain as PBMs take big cuts, prompting urgent calls for reform to protect patient care and community pharmacies.
What pharmacy technicians say would actually make them feel seen on World Pharmacy Technician Day, and the other 364 days of the year.
The analysis is not a head-to-head trial, and the weight loss gap reached statistical significance under 1 of 2 estimands.
A 1.6-million-birth analysis finds that adoption of a 2016 trial's antibiotic protocol climbed sharply in US hospitals, with a drop in infection rates.
New findings suggest semaglutide's benefits may extend well beyond diabetes and weight loss and into airway disease and mood disorders.
Advertisement
Advertisement